International Drug & Explosives Detection Company IDenta Corp. Announces Orders and Marketing Agreements
JERUSALEM, Jan. 24, 2012 /PRNewswire/ -- IDenta Corp. (OTC: IDTA) CEO Yaacov Shoham today announced the following sales:
In the first 3 weeks of 2012, we have already received orders totaling $74,450.
Orders were from:
France - 22850 usd
India - 10200 usd
Argentina- 25000 usd
Israel - 15900 usd
Germany- 500 usd
The orders for this 3 week period represent 36% of the entire orders for 2011 (in only 3 weeks, holiday weeks!!!!!)
"This is only the beginning, because we are expecting many more orders from other countries including the USA in the near future."
Mr. Shoham also announced the following marketing agreements:
COHEN-ABELLA TRADING CORPORATION in the Philippines.
STN – Security Team Network from Argentina, www.securityteam.co.ar in Chile, Colombia and Ecuador. STN is already representing IDenta Corp. successfully in Argentina.
"The agreements were signed last week in Israel after meetings with the two companies."
Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.
Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, email@example.com, www.drugsdetector.com www.identa.biz. www.identa-corp.com
SOURCE IDenta Corp.